Introduction
============

The addition of an *O*-linked *N*-acetylglucosamine (*O*-GlcNAc) is a dynamic post-translational modification (PTM) of serine and threonine residues of nuclear and cytoplasmic proteins that is recognized as a key regulatory process involved in nuclear transport, transcription and translation, signal transduction, cytoskeletal reorganization, proteasomal degradation and apoptosis.^[@bib1]^ The regulatory *O*-GlcNAcylation process, which is catalyzed by coordinated actions of *O*-GlcNAc transferase and *O*-GlcNAc amidase, is reversible and often reciprocal with serine and threonine phosphorylation at the same or nearby residues.^[@bib2]^ The dynamic interplay between *O*-GlcNAcylation and phosphorylation and their regulatory mechanisms in signaling, transcription and chronic disease have been extensively reviewed by Hart *et al.*^[@bib3]^ More recently, Mishra *et al.* hypothesized that phosphorylation could be a prerequisite for *O*-GlcNAcylation and that tyrosine phosphorylation has a role in the interplay between serine/threonine *O*-GlcNAcylation and phosphorylation.^[@bib4]^

Various enrichment strategies for isolating *O*-GlcNAcylated peptides coupled with mass spectrometry (MS) techniques have been used to map *O*-GlcNAc sites. These methods include GlcNAc-binding lectin wheat germ agglutinin (WGA) affinity purification,^[@bib5],\ [@bib6]^ enzymatic labeling of protein *O*-GlcNAc with *N*-azidoacetylgalatosamine, chemical attachment of a biotin tag followed by affinity purification and ETD MS to identify *O*-GlcNAc sites,^[@bib7]^ and selective enrichment of *O*-GlcNAcylated peptides using BEMAD or biotin pentylamine tagging followed by affinity chromatography and MS analysis.^[@bib8]^ Despite such technical advances for *O*-GlcNAcylated protein identification and *O*-GlcNAcylation site mapping, the study of the dynamics between *O*-GlcNAcylation and phosphorylation has been limited owing to the technical difficulty of selectively co-isolating both forms. Hence, non-destructive, highly selective methods for the efficient isolation and detection of PTMs would provide valuable insights into the fundamental roles of *O*-GlcNAcylation and phosphorylation in cellular processes.

Here, we describe a method for the isolation, concurrent identification and quantification of *O*-GlcNAcylated and phosphorylated proteins. This method is based on the separation of *O*-GlcNAcylated and phosphorylated peptides using TiO~2~ affinity chromatography, removal of *O*-GlcNAc and phosphate groups by β-elimination, conjugation with normal dithiothreitol (DTT; d0-DTT) or isotopically labeled DTT (d6-DTT), and isolation of DTT-conjugated peptides by thiol affinity chromatography. The isolated peptides are then identified and quantified by MS. Using this method, we investigated the concurrent transitory PTM events between *O*-GlcNAcylation and phosphorylation. Furthermore, we mapped potential reciprocal PTM sites on synapsin-1 and tau peptides isolated from mouse brain synaptosomes.

Materials and methods
=====================

Isolation of mouse synaptosomes
-------------------------------

SJL mice (Jackson Labs, Bar Harbor, ME, USA) were anesthetized and killed by cervical dislocation. The hippocampus and cortex were removed and immediately stored at 4 °C in the homogenization medium (0.075 M sucrose, 0.225 M sorbitol, 1 mℳ ethylene glycol tetraacetic acid, 0.1% fatty acid-free bovine serum albumin and 10 mℳ Tris-HCl, pH 7.4). The tissue was homogenized with 10--15 strokes in a glass homogenizer. Homogenates were centrifuged to remove unbroken cells (1000 g, 5 min, 4 °C). The supernatants were collected by centrifugation at 4 °C and 12 000 *g* for 10 min. The pellet contains mitochondria and synaptosomes. The pellet was resuspended in medium B (5 mℳ potassium phosphate, 0.32 M sorbitol, pH 7.5) and centrifuged at 4 °C and 12 000 *g* for 10 min. The pellet was resuspended in 2 ml of medium B and then added to 14 ml of a two-phase mixture (the final concentrations of 6.4% (w/w) Dextran T500, 0.32 M sorbitol, 6.4% (w/w) polyethylene glycol, 5 mℳ potassium phosphate and 0.1 mℳ EDTA, pH 7.8). After 20 inverting of the tube, the two-phase was centrifuged at 4 °C and 1500 *g* for 1 min. At this step, the upper phase contains synaptosomes, which was added to medium A (1 mℳ potassium EDTA, 10 mℳ Tris-HCl and 0.32 M sucrose pH 7.4). Synaptosomes were obtained by centrifugation at 4 °C and 5500 *g* for 5 min.^[@bib9]^

In-solution digestion of proteins
---------------------------------

Proteins isolated from mouse brain synaptosomes were dissolved in 8 M urea and reduced with 10 mℳ DTT for 1 h at room temperature (RT), followed by alkylation with 30 mℳ iodoacetamide for 30 min at RT in the dark. Proteins were digested with sequencing grade-modified trypsin (Promega, Madison, WI, USA) at a concentration of 1:50 (w/w) overnight at 37 °C. Peptides were desalted on a C18 Sep-Pak cartridge (Waters Corp., Milford, MA, USA).

Separation of *O*-GlcNAcylated and phosphorylated peptides using a TiO~2~ affinity column
-----------------------------------------------------------------------------------------

A TiO~2~ affinity column (GL Sciences, Torrance, CA, USA) was prewashed with 20 μl buffer A (0.5% TFA in 80% ACN) and then equilibrated with 20 μl buffer B (0.4% TFA and 25% lactic acid or acetic acid in 60% ACN). A mixture of *O*-GlcNAcylated (TAPT**(*O*-GlcNAc)**STIAPG) and phosphorylated (TAPT**(phospho)**STIAPG) synthetic peptides (Invitrogen, St.Louis, MO, USA) in 150 μl buffer B was loaded onto the column. Following sample loading, the column was centrifuged at 1000 *g* for 4 min, and the flow-through fraction was saved. The column was then washed with 20 μl buffer B by centrifugation at 3000 *g* for 1 min followed by 20 μl buffer A, and the flow-through fractions were again saved. All the flow-through fractions containing *O*-GlcNAcylated peptide were combined. Phosphorylated peptide was eluted with 50 μl 5% NH~4~OH by two rounds of centrifugation at 1000 *g* for 3 min, followed by centrifugation with 50 μl 30% ACN at 1000 *g* for 3 min. Both flow-through and elution fractions were desalted with a C18 Sep-Pak cartridge (Waters Corp.), which was prewashed with 100% ACN and equilibrated with 0.1% acetic acid in H~2~O. The pH of the samples was adjusted to below 3.0 by adding 10% formic acid (FA), and samples were then loaded onto C18 columns. The columns were washed with 0.1% acetic acid, and the peptides were eluted with 80% ACN in 0.1% acetic acid in H~2~O. Each eluate was evaporated in a Speed-Vac concentrator (Labconco, Kansas City, MO, USA). The peptides were reconstituted in Solvent A (2% ACN and 0.1% FA in H~2~O) for MS analysis.

BEMAD reaction
--------------

Dried peptides were β-eliminated and subjected to BEMAD via resuspension in 90 μl 90% MeOH, 0.25 M Ba(OH)~2~, and 10 mℳ d0- or d6-DTT (Cambridge Isotope Laboratories, Andover, MA, USA), and the reaction mixture was incubated at 45 °C for 2 h. The reaction was quenched by adding 0.3 M H~2~SO~4~ (pH 5.0). Peptides were dried, cleaned using a C18 Sep-Pak cartridge (Waters Corp.) and dried in a Speed-Vac (Labconco).

Thiol affinity chromatography
-----------------------------

Thiopropyl sepharose 6B beads (GE HealthCare Life Sciences, Pittsburgh, PA, USA) were suspended with de-gassed high-pressure liquid chromatography (HPLC)-grade H~2~O. The swelled beads were transferred onto spin columns and washed seven times with 500 μl de-gassed H~2~O. Dried DTT-labeled peptides were suspended with 600 μl TBS-EDTA (20 mℳ Tris, 150 mℳ NaCl and 1 mℳ EDTA, pH 7.5), mixed with activated Thiopropyl sepharose beads and incubated at RT for 4 h while rotating. After incubation, beads were washed seven times with 500 μl TBS-EDTA and then incubated with elution buffer solution (20 mℳ free DTT in TBS-EDTA) at RT for 1 h before collecting the eluent. The elution fraction was acidified with 10% FA, desalted with a C18 Sep-Pak cartridge and dried in a Speed-Vac concentrator (Labconco). The sample was stored at −80 °C until use.

Mass spectrometry analysis
--------------------------

Synthetic peptides were analyzed on an Agilent 6430 triple quadrupole mass spectrometer (Agilent Technologies, Santa Clara, CA, USA) coupled with an Agilent 1200 nano-HPLC interfaced with the HPLC-chip spray system. The peptides were resuspended in solvent A (0.1% FA in water) and separated on the HPLC-chip column, ZORBAX 300SB-C18 (5 μm, 160 nl enrichment column and 75 μm × 150 mm analytical column) with a linear gradient of 0--40% solvent B (0.1% FA in ACN) for 20 min at a flow rate of 300 nl min^−1^. The spray voltage was set to 1.9 kV and the temperature of nitrogen drying gas was set to 325 °C in the positive ion mode. Full scan range was set from 300 to 1700 *m/z* and the scan time was set to 500 ms.

Thiol-enriched peptides were resuspended in 50 μl solvent A (2% ACN, 0.1% FA in H~2~O), and 5 μl of the sample was analyzed by MS with a house-packed 75 μm (inner diameter micro-capillary) × 10-cm C~18~ column with a 2--38% gradient of solvent B (98% ACN, 0.1% FA in H~2~O) for 90 min at a flow rate of 300 nl min^−1^. MS spectra were recorded on an LTQ-velos (Thermo Fisher Scientific, San Jose, CA, USA) interfaced with a nano-HPLC system (Easy *n*LC, Thermo Fisher Scientific). Standard MS conditions were a spray voltage set to 1.9 kV and a heated capillary temperature of 325 °C. Full scans were acquired in the LTQ analyzer at 400--1400 *m/z,* and the LTQ was operated in a data-dependent mode with one survey MS scan followed by five MS/MS scans on the five most intense ions. Tandem mass spectra were analyzed using the Sorcerer-SEQUEST search engine. The search was performed using the Uniprot database for *Mus musculus* (mouse, 10090), with carbamidomethyl as a fixed modification and variable parameters set for oxidation of methionine and DTT-derivatized peptides including mass increases of 136.25 Da (d0-DTT) and 142.25 Da (d6-DTT) for serine and threonine. We also allowed for a mass increase of 120.25 Da (d0-DTT) and 126.25 Da (d6-DTT) for cysteine.

Results
=======

Metal affinity chromatographic separation of *O*-GlcNAcylated and phosphorylated peptides
-----------------------------------------------------------------------------------------

We first evaluated the performance of several different metal affinity matrices (TiO~2~, IMAC and ZrO~2~/TiO~2~) for the separation of *O*-GlcNAcylated (TAPT**(*O*-GlcNAc)**STIAPG) and phosphorylated (TAPT**(phospho)**STIAPG) synthetic peptides. Peptide separation efficiency was assessed by measuring Liquid chromatography--mass spectrometry (LC-MS) peptide elution profiles. The TiO~2~-column was found to provide better peptide separation efficiency than other metal affinity matrices (data not shown). Therefore, we sought to further optimize conditions for TiO~2~-column separation of the retentate fraction (phosphopeptides) and the flow-through fraction (*O*-GlcNAc peptides) for the subsequent BEMAD reaction.

[Figure 1](#fig1){ref-type="fig"} shows an LC/MS profile of the *O*-GlcNAcylated peptide ([Figures 1a](#fig1){ref-type="fig"}, M+2H, 559.6) and the phosphorylated peptide ([Figures 1b](#fig1){ref-type="fig"}, M+2H, 498.2) isolated from the TiO~2~-column separation with a lactic acid sample loading/binding buffer. The peak area of extracted ion chromatogram of the *O*-GlcNAcylated peptide was much less than the level of the phosphorylated peptide. Moreover, the LC/MS profile of the *O*-GlcNAcylated peptide fraction showed multiple peaks eluted at the late chromatographic gradient condition, indicating that the C18 sample clean-up did not completely remove the acid and other unknown impurities. We also found that owing to its high viscosity and acidity, the lactic acid present in the column-binding buffer interfered with the BEMAD reaction for the flow-through fraction (containing the *O*-GlcNAcylated peptide). Replacing lactic acid with acetic acid in the sample loading/binding buffer improved the *O*-GlcNAcylated peptide recovery ([Figure 2](#fig2){ref-type="fig"}).

Selective enrichment of *O*-GlcNAcylated and phosphorylated synthetic peptides in a complex peptide mixture
-----------------------------------------------------------------------------------------------------------

With the acetic acid modifier, we further evaluated the TiO~2~-column for selective isolation of *O*-GlcNAcylated and phosphorylated synthetic peptides in a complex peptide sample mixture. Equal amounts of *O*-GlcNAcylated and phosphorylated synthetic peptides (1 pmol each) were mixed with 400 μg trypsin-digested peptides obtained from mouse brain synaptosomal proteins. After separation of the peptide mixtures using the TiO~2~-column, the retentate and flow-through fractions were analyzed by selected ion monitoring for both the *O*-GlcNAcylated (M+2H, 559.6) and phosphorylated (M+2H, 498.2) peptides using a triple quadruple mass spectrometer. We detected only the phosphorylated peptide ([Figure 3b](#fig3){ref-type="fig"}) but not the *O*-GlcNAcylated peptide ([Figure 3a](#fig3){ref-type="fig"}). However, when the flow-through and retentate fractions were processed with the BEMAD reaction, labeled with d0-DTT and d6-DTT, and purified using thiol affinity chromatography, we detected both d0-DTT-labeled phosphorylated peptide ([Figure 4a](#fig4){ref-type="fig"}) and d6-DTT-labeled *O*-GlcNAcylated peptide ([Figure 4b](#fig4){ref-type="fig"}). Their corresponding ions (peptide masses), phosphorylated peptide (M+H, 1051.4) and *O*-GlcNAcylated peptide (M+H, 1057.4) ([Figure 4c](#fig4){ref-type="fig"}) were detected with an equal intensity (expected ratio of 1:1) with a mass difference of 6 Da. These results indicate that the *O*-GlcNAcylated and phosphorylated peptides present in the complex mixture were well separated and selectively enriched through the TiO~2~-column separation and thiol affinity chromatography.

Concurrent identification and quantification of *O*-GlcNAcylated and phosphorylated sites of synapsin-1 and tau proteins in mouse brain synaptosomes
----------------------------------------------------------------------------------------------------------------------------------------------------

Next, we attempted to identify *O*-GlcNAcylated and phosphorylated site modifications of cytoplasmic and nuclear proteins in mouse brain synaptosomes. The isolated proteins were trypsinized, and the resulting tryptic peptides were separated into phosphorylated and *O*-GlcNAcylated fractions using the TiO~2~-column and labeled with d0-DTT and d6-DTT, respectively ([Figure 5](#fig5){ref-type="fig"}). Mixed d0/d6-DTT-labeled peptides were enriched with thiol affinity chromatography and then analyzed by liquid chromatography--mass spectrometry. By searching a sequence database, we identified peptide sequences of both synapsin-1 and tau showing potential reciprocal sites between *O*-GlcNAcylation and phosphorylation. andem MS spectra of the synapsin-1 peptide sequence ^603^QASQAGPGPR^612^ showed that the Ser^605^ residue was conjugated with either d0-DTT ([Figure 6a](#fig6){ref-type="fig"}) or d6-DTT ([Figure 6b](#fig6){ref-type="fig"}), indicating that this residue was formerly modified by either phosphorylation or *O*-GlcNAcylation, respectively. We also identified the Ser^692^ residue of a tau peptide ^688^SPVVSGDTSPR^698^, and its tandem MS spectra clearly indicated that this residue was modified by either *O*-GlcNAcylation ([Figure 6c](#fig6){ref-type="fig"}) or phosphorylation ([Figure 6d](#fig6){ref-type="fig"}). These results were further confirmed by an *O*-GlcNAcylation prediction tool (dbOGAP, <http://cbsb.lombardi.georgetown.edu/OGAP.html>)^[@bib10]^ and a phosphorylation prediction tool (NetPhos 2.0 server, <http://www.cbs.dtu.dk/services/NetPhos>).^[@bib11]^ The Ser^605^ residue of synapsin-1 was predicted to be a site of both phosphorylation (prediction score, 0.933) ([Figure 7a](#fig7){ref-type="fig"}) and *O*-GlcNAcylation (prediction score, 0.4188) ([Figure 7b](#fig7){ref-type="fig"}), and it also appeared to be a potential reciprocal site ([Figure 7c](#fig7){ref-type="fig"}) based on the results of another prediction tool (YinOYang 1.2, <http://www.cbs.dtu.dk/services/YinOYang>).^[@bib12]^ Using the same prediction tools, the Ser^692^ residue of the tau peptide ^688^SPVVSGDTSPR^698^ was also predicted to be a site of phosphorylation (prediction score, 0.792) ([Figure 7d](#fig7){ref-type="fig"}) and *O*-GlcNAcylation (prediction score, 0.6152) ([Figure 7e](#fig7){ref-type="fig"}), as well as a potential reciprocal site ([Figure 7f](#fig7){ref-type="fig"}).

Discussion
==========

Recent advances in techniques for enriching *O*-GlcNAcylated and phosphorylated peptides followed by identification of either site modification on ser/threonine residues by MS analysis have facilitated studies of the fundamental roles of protein *O*-GlcNAcylation in cellular processes. Despite the importance of the reciprocal relationship between protein *O*-GlcNAcylation and phosphorylation in nuclear transport, transcription and translation, signal transduction, cytoskeletal reorganization, proteasomal degradation and apoptosis,^[@bib3]^ a reliable method for concurrently identifying *O*-GlcNAcylation and phosphorylation is needed to enhance our knowledge of key regulatory post-translational dynamics in cellular processes. This report describes our strategy for concurrently identifying *O*-GlcNAcylated and phosphorylated peptides in a quantitative manner using TiO~2~-column enrichment and BEMAD methods. Although this strategy is similar to that used to identify *O*-GlcNAcylated proteins,^[@bib8]^ we implemented combined metal affinity chromatography and BEMAD approaches to concurrently enrich *O*-GlcNAcylated and phosphorylated peptides and thereby map the two PTMs at the same time.

Metal affinity chromatography utilizing TiO~2~, IMAC or ZnO~2~ enriches phosphorylated peptides through chelating phosphate groups at the immobilized divalent cation. As a result, peptide mixtures can be separated into column retentate and flow-through fractions, with the retentate fraction mostly containing phosphorylated peptides and the flow-through fraction mostly containing *O*-GlcNAcylated peptides and other non-phosphorylated peptides. Out of the three different types of metal affinity chromatographic columns, we found that TiO~2~-based column chromatography affords the most efficient separation between phosphorylated and *O*-GlcNAcylated peptides. As lactic acid in the TiO~2~-based column chromatography interfered with the DTT conjugation reaction onto the peptides, we replaced the acid modifier with acetic acid. A major benefit of using acetic acid for peptide separation is that the acid can be easily removed from the flow-through fraction by simple vacuum evaporation. We also found that DTT conjugation to the peptide mixtures in the flow-through fraction reduced the sample complexity by isolating a subset of peptides, thereby enhancing *O*-GlcNAcylated peptide detection. As the BEMAD reaction also affects cysteine-containing peptides in the flow-through fraction, however, perchlorate oxidation of the cysteine residues may reduce the co-purification of cysteine-containing peptides with *O*-GlcNAcylated peptides.^[@bib8]^ Nonetheless, we successfully demonstrated that the TiO~2~-column enrichment/BEMAD reaction enables the reciprocal site mapping of synapsin-1 and tau proteins in mouse brain synaptosomes. By mapping *O*-GlcNAcylated and phosphorylated sites on synaptin-1, we identified that Ser^605^ in the synapsin-1 peptide sequence ^603^QASQAGPGPR^612^ is both phosphorylated and *O*-GlcNAcylated. These findings are consistent with previous studies in which *O*-GlcNAcylation of a specific serine residue was found to modulate its regulatory function.^[@bib13]^ Several research groups, including that of Jovanovic *et al.,* report that this neuronal protein regulates synaptic vesicle trafficking through a reciprocal process between phosphorylation and dephosphorylation of specific synapsin-1 sites,^[@bib14],\ [@bib15],\ [@bib16]^ and this particular serine residue is reported to be a potential reciprocal site involved in regulating hippocampal synaptic plasticity.^[@bib17]^ We also identified that Ser^692^ in the tau peptide sequence ^688^SPVVSGDTSPR^698^ is a potential reciprocal site in mouse brain synaptosomes. Interestingly, concurrent alterations of tau *O*-GlcNAcylation and phosphorylation have been found to be involved in impaired brain glucose uptake/metabolism.^[@bib18]^

In conclusion, we demonstrated that a combined TiO2 affinity separation and BEMAD method allows selective enrichment of *O*-GlcNAcylated and phosphorylated peptides, which permits the assessment of potential cross-talk between these two PTMs and their regulatory roles. To the best of our knowledge, this is the first systematic assessment of specific serine reciprocal site occupancy of *O*-GlcNAcylation and phosphorylation of synapsin-1 and tau in mouse brain synaptosomes. Future studies can provide further validation of their functional roles in the pathogenesis of various human diseases such as diabetes, Alzheimer\'s disease and cancer.
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![Separation of synthetic peptides using TiO~2~ affinity chromatography with a lactic acid sample loading/binding buffer. (**a**) Extracted ion chromatogram of the TiO~2~-column flow-through fraction, with the inset showing the doubly charged peptide ion (*m*/*z*, 559.8) corresponding to the *O*-GlcNAcylated synthetic peptide (TAPT**(*O*-GlcNAc)**STIAPG). (**b**) Extracted ion chromatogram of the TiO~2~-column retentate fraction, with the inset showing singly (*m*/*z*, 995.4) and doubly (*m*/*z*, 498.2) charged peptide ions corresponding to the phosphorylated synthetic peptides (TAPT**(phospho)**STIAPG).](emm201356f1){#fig1}

![Separation of synthetic peptides using TiO~2~ affinity chromatography with an acetic acid-binding buffer. (**a**) Extracted ion chromatogram of the TiO~2~-column flow-through fraction, with the inset showing singly (*m*/*z*, 1118.6) and doubly (*m*/*z*, 559.8) charged peptide ions corresponding to the *O*-GlcNAcylated synthetic peptide (TAPT**(*O*-GlcNAc)**STIAPG). (**b**) Extracted ion chromatogram of the TiO~**2**~-column elution fraction, with the inset showing singly (*m*/*z*, 995.4) and doubly (*m*/*z*, 498.2) charged peptide ions corresponding to the phosphorylated peptides (TAPT**(phospho)**STIAPG). The ratio between the two peptides was 1:1.](emm201356f2){#fig2}

![Detection of *O*-GlcNAcylated and phosphorylated peptides in a complex peptide mixture (synaptosome) via TiO~2~ affinity enrichment using an acetic acid-binding buffer. (**a**) LC/MS trace of the TiO~2~-column flow-through fraction of *O*-GlcNAcylated and phosphorylated peptides (1:1 ratio) in a complex peptide mixture. (**b**) LC/MS trace of the TiO~2~-column retentate fraction of *O*-GlcNAcylated and phosphorylated peptides (1:1 ratio) in a complex peptide mixture. Extracted ion chromatogram of the phosphorylated peptide (marked with an asterisk), with the inset showing singly (*m*/*z*, 995.4) and doubly (*m*/*z*, 498.2) charged peptide ions corresponding to the phosphorylated peptides (TAPT**(phospho)**STIAPG).](emm201356f3){#fig3}

![Selective enrichment of *O*-GlcNAcylated and phosphorylated synthetic peptides in a synaptosome sample via BEMAD followed by thiol affinity chromatography. (**a**) LC/MS trace of d0-DTT-conjugated phosphorylated peptide. (**b**) LC/MS trace of d6-DTT-conjugated *O*-GlcNAcylated peptide. (**c**) MS trace of singly charged d0-DTT-labeled phosphorylated peptide (M+H, 1051.4) and d6-DTT-labeled *O*-GlcNAcylated peptide (M+H, 1057.4).](emm201356f4){#fig4}

![Experimental workflow for concurrent identification of phosphorylated and *O*-GlcNAcylated peptides.](emm201356f5){#fig5}

![Tandem spectra of d0-DTT- and d6-DTT-labeling of synaptin-1 and tau peptides. (**a**) Tandem spectrum of d0-DTT- and (**b**) d6-DTT-labeling at the Ser^605^ residue of the synapsin-1 peptide ^603^QASQAGPGPR^612^. (**c**) Tandem spectrum of d0-DTT- and (**d**) d6-DTT-labeling at the Ser^692^ residue of the tau peptide ^688^SPVVSGDTSPR^698^. All corresponding a-, b- and y-ion series are assigned.](emm201356f6){#fig6}

![Prediction of phosphorylation, *O*-GlcNAcylation and reciprocal sites for synapsin-1 and tau. (**a**) Predicted phosphorylation sites and (**b**) *O*-GlcNAcylation sites of synapsin-1. Prediction scores of phosphorylation and *O*-GlcNAcylation for Ser^605^ (marked by an arrow) were \>0.5, and (**c**) the serine residue was identified as a potential reciprocal site (Ying--Yang score of 0.5). The horizontal line indicates the threshold (0.5) for modification potential, and the vertical lines show the potential phosphorylation and *O*-GlcNAcylation sites for the serine residue in the synapsin-1 peptide. (**d**) Predicted phosphorylation sites and (**e**) *O*-GlcNAcylation sites of tau. Prediction scores of phosphorylation and *O*-GlcNAcylation for Ser^692^ (marked by an arrow) were greater than 0.7 and (**f**) the serine residue as identified as a potential reciprocal site (Ying--Yang score of 0.6).](emm201356f7){#fig7}
